speb/financial-data huggingface dataset:
CPHI income_statement (annual, 2025-12-31) — Normalized Income: -3188574.00
CPHI income_statement (quarterly, 2025-12-31) — Normalized Income: -1222135.00
CPHI balance_sheet (annual, 2025-12-31) — Notes Receivable: 0.00
CPHI balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 0.00
CPHI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 148261.00
CPHI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 151990.00
CPHI income_statement (annual, 2025-12-31) — Operating Income: -3088540.00
CPHI income_statement (quarterly, 2025-12-31) — Operating Income: -1200762.00
CPHI income_statement (annual, 2025-12-31) — Operating Revenue: 4144268.00
CPHI income_statement (quarterly, 2025-12-31) — Operating Revenue: 1225997.00
CPHI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 15522002.00
CPHI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 15522002.00
CPHI balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3704015.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3704015.00
CPHI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 11582646.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 11582646.00
CPHI balance_sheet (annual, 2025-12-31) — Other Equity Interest: -180000.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -180000.00
CPHI income_statement (annual, 2025-12-31) — Other Gand A: 2451459.00
CPHI income_statement (quarterly, 2025-12-31) — Other Gand A: 1078616.00
CPHI income_statement (annual, 2025-12-31) — Other Income Expense: 1018.00
CPHI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 24479999.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 24479999.00
CPHI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3472.00
CPHI income_statement (annual, 2025-12-31) — Other Operating Expenses: -151556.00
CPHI income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -451.00
CPHI balance_sheet (annual, 2025-12-31) — Other Properties: 181828.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Properties: 181828.00
CPHI balance_sheet (annual, 2025-12-31) — Other Receivables: 49261.00
CPHI balance_sheet (quarterly, 2025-12-31) — Other Receivables: 49261.00
CPHI balance_sheet (annual, 2025-12-31) — Payables: 1242987.00
CPHI balance_sheet (quarterly, 2025-12-31) — Payables: 1242987.00
CPHI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1593630.00
CPHI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1593630.00
CPHI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1919506.00
CPHI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1919506.00
CPHI balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CPHI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CPHI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 89199.00
CPHI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 89199.00
CPHI income_statement (annual, 2025-12-31) — Pretax Income: -3187556.00
CPHI income_statement (quarterly, 2025-12-31) — Pretax Income: -1222135.00
CPHI balance_sheet (annual, 2025-12-31) — Properties: 0.00
CPHI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CPHI cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -77927.00
CPHI cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -5313.00
CPHI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -59324.00
CPHI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -454.00
CPHI balance_sheet (annual, 2025-12-31) — Raw Materials: 843603.00
CPHI balance_sheet (quarterly, 2025-12-31) — Raw Materials: 843603.00
CPHI balance_sheet (annual, 2025-12-31) — Receivables: 290673.00
CPHI balance_sheet (quarterly, 2025-12-31) — Receivables: 290673.00
CPHI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4276218.00
CPHI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1075222.00
CPHI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1579169.00
CPHI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 572959.00
CPHI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1255093.00
CPHI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -780161.00
CPHI income_statement (annual, 2025-12-31) — Research And Development: 280901.00
CPHI income_statement (quarterly, 2025-12-31) — Research And Development: 190041.00
CPHI balance_sheet (annual, 2025-12-31) — Retained Earnings: -47214235.00
CPHI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -47214235.00
CPHI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 375786.00
CPHI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 109342.00
CPHI income_statement (annual, 2025-12-31) — Selling General And Administration: 2827245.00
CPHI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1187958.00
CPHI balance_sheet (annual, 2025-12-31) — Share Issued: 15522002.00
CPHI balance_sheet (quarterly, 2025-12-31) — Share Issued: 15522002.00
CPHI income_statement (annual, 2025-12-31) — Special Income Charges: 1018.00
CPHI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 22739752.00
CPHI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 22739752.00
CPHI balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1740247.00
CPHI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1740247.00
CPHI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CPHI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CPHI income_statement (annual, 2025-12-31) — Tax Provision: 0.00
CPHI income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
CPHI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CPHI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CPHI balance_sheet (annual, 2025-12-31) — Total Assets: 30999464.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Assets: 30999464.00
CPHI balance_sheet (annual, 2025-12-31) — Total Capitalization: 22739752.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 22739752.00
CPHI balance_sheet (annual, 2025-12-31) — Total Debt: 3887191.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Debt: 3887191.00
CPHI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 22739752.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 22739752.00
CPHI income_statement (annual, 2025-12-31) — Total Expenses: 7232808.00
CPHI income_statement (quarterly, 2025-12-31) — Total Expenses: 2426759.00
CPHI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 8259712.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 8259712.00
CPHI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 28653057.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 28653057.00
CPHI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 859353.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 859353.00
CPHI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -3239078.00
CPHI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1200195.00
CPHI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 351904.00
CPHI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 351904.00
CPHI income_statement (annual, 2025-12-31) — Total Unusual Items: 1018.00
CPHI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1018.00
CPHI balance_sheet (annual, 2025-12-31) — Work In Process: 457817.00
CPHI balance_sheet (quarterly, 2025-12-31) — Work In Process: 457817.00
CPHI balance_sheet (annual, 2025-12-31) — Working Capital: -5053952.00
CPHI balance_sheet (quarterly, 2025-12-31) — Working Capital: -5053952.00
CPHI income_statement (annual, 2025-12-31) — Write Off: -1018.00
CPHI income_statement (quarterly, 2026-03-31) — +Operating Expense: 1402751.00
CPHI income_statement (quarterly, 2026-03-31) — +Total Revenue: 983536.00
CPHI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 837108.00
CPHI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 196262.00
CPHI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -34162377.00
CPHI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 73504819.00
CPHI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -9434.00
CPHI cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 825282.00
CPHI cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 825282.00
CPHI cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: -2881.00
CPHI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 25602002.00
CPHI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.04
CPHI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 345112.00
CPHI balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 9452781.00
CPHI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 163680.00
CPHI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 40522.00
CPHI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 168474.00
CPHI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 168474.00
CPHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -79325.00
CPHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CPHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -55292.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -67771.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Inventory: 247492.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -51376.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Payable: -82029.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -82029.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 8653.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -14019.00
CPHI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 108721.00
CPHI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -134617.00
CPHI balance_sheet (quarterly, 2026-03-31) — Common Stock: 40522.00
CPHI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 37024190.00
CPHI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 698049.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 311336.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Assets: 2003555.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 71386.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Debt: 3692422.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3763808.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 61746.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 61746.00
CPHI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7267678.00
CPHI cash_flow (quarterly, 2026-03-31) — Depreciation: 155288.00
CPHI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 980570.00
CPHI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 980570.00
CPHI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 25602002.00
CPHI income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.04
CPHI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — EBIT: -1117117.00
CPHI income_statement (quarterly, 2026-03-31) — EBITDA: -136547.00
CPHI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -42021.00
CPHI cash_flow (quarterly, 2026-03-31) — End Cash Position: 168474.00
CPHI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -79325.00
CPHI balance_sheet (quarterly, 2026-03-31) — Finished Goods: 1702331.00
CPHI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -55292.00
CPHI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 1446.00
CPHI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 12016232.00
CPHI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1226272.00
CPHI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 39081436.00
CPHI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 205696.00
CPHI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 38221176.00
CPHI income_statement (quarterly, 2026-03-31) — Gross Profit: 285487.00
CPHI income_statement (quarterly, 2026-03-31) — Interest Expense: 26031.00
CPHI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 26031.00
CPHI income_statement (quarterly, 2026-03-31) — Interest Income: 147.00
CPHI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 147.00
CPHI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 15758.00
CPHI balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -1117335.00
CPHI balance_sheet (quarterly, 2026-03-31) — Inventory: 1498501.00
CPHI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 40716612.00
CPHI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
CPHI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 92294.00
CPHI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 92294.00
CPHI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -79325.00
CPHI balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 28606520.00
CPHI balance_sheet (quarterly, 2026-03-31) — Net Debt: 3523948.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1143148.00
CPHI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1143148.00
CPHI income_statement (quarterly, 2026-03-31) — Net Interest Income: -25884.00
CPHI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -79325.00
CPHI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -79325.00
CPHI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -25884.00
CPHI balance_sheet (quarterly, 2026-03-31) — Net PPE: 4058799.00
CPHI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
CPHI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -2057246.00
CPHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 759628.00
CPHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 759628.00
CPHI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -136547.00
CPHI income_statement (quarterly, 2026-03-31) — Normalized Income: -1143148.00
CPHI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -55292.00
CPHI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1446.00
CPHI income_statement (quarterly, 2026-03-31) — Operating Income: -1117264.00
CPHI income_statement (quarterly, 2026-03-31) — Operating Revenue: 983536.00
CPHI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 40522002.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3692422.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 12016232.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -180000.00
CPHI income_statement (quarterly, 2026-03-31) — Other Gand A: 1226272.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 39081436.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Properties: 161875.00
CPHI balance_sheet (quarterly, 2026-03-31) — Other Receivables: 61657.00
CPHI balance_sheet (quarterly, 2026-03-31) — Payables: 1207282.00
CPHI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1518618.00
CPHI balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1923506.00
CPHI balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CPHI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 78661.00
CPHI income_statement (quarterly, 2026-03-31) — Pretax Income: -1143148.00
CPHI balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CPHI income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: -2881.00
CPHI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
CPHI balance_sheet (quarterly, 2026-03-31) — Raw Materials: 750019.00
CPHI balance_sheet (quarterly, 2026-03-31) — Receivables: 257919.00
CPHI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 698049.00
CPHI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 980570.00
CPHI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -79325.00
CPHI income_statement (quarterly, 2026-03-31) — Research And Development: 83762.00
CPHI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -48357383.00
CPHI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 95598.00
CPHI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1321870.00
CPHI balance_sheet (quarterly, 2026-03-31) — Share Issued: 40522002.00
CPHI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 37024190.00
CPHI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2057246.00
CPHI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CPHI income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
CPHI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Assets: 45143790.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 37024190.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Debt: 3856102.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 37024190.00
CPHI income_statement (quarterly, 2026-03-31) — Total Expenses: 2100800.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 8119600.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 43140235.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 851922.00
CPHI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1117264.00
CPHI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 370174.00
CPHI balance_sheet (quarterly, 2026-03-31) — Work In Process: 163486.00
CPHI balance_sheet (quarterly, 2026-03-31) — Working Capital: -5264123.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 10000000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 322000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Cash Equivalents: 95084000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 5000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 227000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Deferred Tax: -652000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Finished Goods: 52828000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -17000.00
CPHN.SW income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 150000000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 10000000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 95000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Net Debt: 4916000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1630000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 165000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
CPHN.SW cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
CPHN.SW cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -6914000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1356000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Other Equity Interest: -63021000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 1619000.00
CPHN.SW balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 32000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: -1230000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1630000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Purchase Of Investment: -78000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Purchase Of PPE: -22965000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CPHN.SW cash_flow (annual, 2021-12-31) — Sale Of Investment: 243000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CPHN.SW cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -6914000.00
CPHN.SW cash_flow (annual, 2021-12-31) — Stock Based Compensation: 180000.00
CPHN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 160968000.00
CPHN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 725351000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 93011000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 93931000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1234373000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -7314000.00
CPHN.SW income_statement (annual, 2022-12-31) — Amortization: 2276000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2276000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 10000000.00
CPHN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 5999868.00
CPHN.SW income_statement (annual, 2022-12-31) — Basic EPS: 16.83
CPHN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 95084000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -33905000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -33905000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 102000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 1200000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 143614000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 143614000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -7800000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -27230000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Change In Payable: 18599000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -23195000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -31826000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: 49020000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 1200000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 398210000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Common Stock Payments: -213000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 22842000.00
CPHN.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 451918000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 382166000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 102000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Debt: 98730000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 98832000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 233472000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 7835000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 24158000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Depreciation: 16353000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18629000.00
CPHN.SW income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 18629000.00
CPHN.SW income_statement (annual, 2022-12-31) — Depreciation Income Statement: 16353000.00
CPHN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 5999868.00
CPHN.SW income_statement (annual, 2022-12-31) — Diluted EPS: 16.83
CPHN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 100953000.00
CPHN.SW income_statement (annual, 2022-12-31) — EBIT: 102491000.00
CPHN.SW income_statement (annual, 2022-12-31) — EBITDA: 121120000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -490000.00
CPHN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 143614000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: -18988000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 63723000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1263000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4527000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 101245000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 1448035000.00
CPHN.SW income_statement (annual, 2022-12-31) — Gross Profit: 273433000.00
CPHN.SW income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CPHN.SW income_statement (annual, 2022-12-31) — Interest Expense: 2335000.00
CPHN.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2335000.00
CPHN.SW income_statement (annual, 2022-12-31) — Interest Income: 67000.00
CPHN.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 67000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -6170000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Inventory: 113097000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 496940000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: -29620000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 10000000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Land And Improvements: 339220000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1270000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Long Term Provisions: 31434000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 725372000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Minority Interest: 1357000.00
CPHN.SW income_statement (annual, 2022-12-31) — Minority Interests: -89000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -213000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income: 100953000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 100953000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 101042000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 100953000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 100953000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 101042000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 101042000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -2799000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1270000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1270000.00
CPHN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2799000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -9705000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 213662000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 4285000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 393683000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 16582000.00
CPHN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 121120000.00
CPHN.SW income_statement (annual, 2022-12-31) — Normalized Income: 100953000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 97628000.00
CPHN.SW income_statement (annual, 2022-12-31) — Operating Income: 112465000.00
CPHN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 725351000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 6000000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4527000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: -2388000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1718000.00
CPHN.SW income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -8021000.00
CPHN.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 61645000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 6546000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Other Properties: 360601000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 31524000.00
CPHN.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Payables: 101420000.00
CPHN.SW income_statement (annual, 2022-12-31) — Pretax Income: 100156000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 13434000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 45107000.00
CPHN.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 451918000.00
CPHN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18629000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1270000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -213000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 397066000.00
CPHN.SW cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CPHN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 4285000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 6000000.00
CPHN.SW income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 398210000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 393683000.00
CPHN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CPHN.SW income_statement (annual, 2022-12-31) — Tax Provision: -886000.00
CPHN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.09
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 666191000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 398210000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 98832000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 399567000.00
CPHN.SW income_statement (annual, 2022-12-31) — Total Expenses: 612886000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 266624000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 284025000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 33152000.00
CPHN.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 112465000.00
CPHN.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: 531000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1863000.00
CPHN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CPHN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 0.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Work In Process: 74160000.00
CPHN.SW balance_sheet (annual, 2022-12-31) — Working Capital: 148694000.00
CPHN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 163929000.00
CPHN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 623982000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 71039000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 71100000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1236977000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1520000.00
CPHN.SW income_statement (annual, 2023-12-31) — Amortization: 1390000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1390000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 10000000.00
CPHN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 5998512.00
CPHN.SW income_statement (annual, 2023-12-31) — Basic EPS: 13.15
CPHN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 143614000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -34646000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -34646000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 1200000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 107640000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 107640000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -27000000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 7443000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Change In Payable: -9904000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 21985000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: 19524000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: -33799000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 1200000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 436271000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Common Stock Payments: -588000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 20861000.00
CPHN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 377250000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 305949000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Debt: 723000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 723000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 120612000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 8848000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 24915000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Depreciation: 17812000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 19202000.00
CPHN.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 19202000.00
CPHN.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 17812000.00
CPHN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 5998512.00
CPHN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 13.15
CPHN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 78885000.00
CPHN.SW income_statement (annual, 2023-12-31) — EBIT: 93369000.00
CPHN.SW income_statement (annual, 2023-12-31) — EBITDA: 112571000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -2175000.00
CPHN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 107640000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -125662000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 75216000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -18871000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3926000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 72620000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 1458954000.00
CPHN.SW income_statement (annual, 2023-12-31) — Gross Profit: 246732000.00
CPHN.SW income_statement (annual, 2023-12-31) — Interest Expense: 1389000.00
CPHN.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1389000.00
CPHN.SW income_statement (annual, 2023-12-31) — Interest Income: 937000.00
CPHN.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 937000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -5456000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Inventory: 102077000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 436994000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -17999000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 10000000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Land And Improvements: 337572000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -98730000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Long Term Provisions: 41260000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 738625000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CPHN.SW income_statement (annual, 2023-12-31) — Minority Interests: -121000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -2416000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -588000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income: 78885000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 78885000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 79006000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 78885000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 78885000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 79006000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 79006000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Interest Income: -656000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -98730000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -98730000.00
CPHN.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -656000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 656000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 221977000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 19063000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 656000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 432345000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 15103000.00
CPHN.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 112571000.00
CPHN.SW income_statement (annual, 2023-12-31) — Normalized Income: 78885000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 109862000.00
CPHN.SW income_statement (annual, 2023-12-31) — Operating Income: 82803000.00
CPHN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 623982000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 5995170.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3926000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: -330000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 48000.00
CPHN.SW income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 11998000.00
CPHN.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 55237000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Other Payable: 7724000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Other Properties: 361896000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 25132000.00
CPHN.SW income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Payables: 81820000.00
CPHN.SW income_statement (annual, 2023-12-31) — Pretax Income: 91980000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Properties: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 11331000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: -2416000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Raw Materials: 40563000.00
CPHN.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 377250000.00
CPHN.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 19202000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: -98730000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -588000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: 435524000.00
CPHN.SW cash_flow (annual, 2023-12-31) — Sale Of Intangibles: 0.00
CPHN.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 19063000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Share Issued: 6000000.00
CPHN.SW income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 436271000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: 432345000.00
CPHN.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CPHN.SW income_statement (annual, 2023-12-31) — Tax Provision: 12974000.00
CPHN.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.14
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Assets: 598191000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: 436271000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Debt: 723000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 436271000.00
CPHN.SW income_statement (annual, 2023-12-31) — Total Expenses: 541179000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 161920000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 292242000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 41308000.00
CPHN.SW income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 82803000.00
CPHN.SW income_statement (annual, 2023-12-31) — Total Other Finance Cost: 204000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Total Tax Payable: 3057000.00
CPHN.SW income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CPHN.SW income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 4830.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Treasury Stock: 408000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Work In Process: 66970000.00
CPHN.SW balance_sheet (annual, 2023-12-31) — Working Capital: 185337000.00
CPHN.SW income_statement (annual, 2024-12-31) — +Operating Expense: 132306000.00
CPHN.SW income_statement (annual, 2024-12-31) — +Total Revenue: 447857000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 34099000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 34099000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Accounts Receivable: 48280000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 48280000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -186640000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -186640000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -356000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -356000.00
CPHN.SW income_statement (annual, 2024-12-31) — Amortization: 2267000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 2267000.00
CPHN.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 5997394.00
CPHN.SW income_statement (annual, 2024-12-31) — Basic EPS: 0.78
CPHN.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 107640000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -22997000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -22997000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 900000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 900000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 31602000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 31602000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 31602000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 31602000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -24000000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Change In Inventory: 1011000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Change In Payable: 9067000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Change In Receivables: 2864000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: 12942000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Changes In Cash: -76580000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Common Stock: 900000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 900000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 209447000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 209447000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Common Stock Issuance: 11000.00
CPHN.SW cash_flow (annual, 2024-12-31) — Common Stock Payments: -502000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Construction In Progress: 10206000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 10206000.00
CPHN.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 285547000.00
CPHN.SW balance_sheet (annual, 2024-12-31) — Current Assets: 169632000.00
CPHN.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 169632000.00